Honeydew reports a new topical formulation of Accutane, promising fewer side effects for mild-to-moderate acne, but oral isotretinoin remains the cure for persistent cases.
This item is available in full to subscribers.
To continue reading, you will need to either log in to your subscriber account, below, or purchase a new subscription.
Please log in to continue |